Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis

Clinical trial NCT04448106 · UNKNOWN

Trial details

NCT number: NCT04448106
Sponsor: Celltex Therapeutics Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip Osteoarthritis Shoulder

Start date: 2023-09-25
Primary completion: 2024-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.